Vanguard Group Inc Neuro Pace Inc Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Neuro Pace Inc stock. As of the latest transaction made, Vanguard Group Inc holds 995,196 shares of NPCE stock, worth $9.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

995,196

Previous 967,716 2.84%

Holding current value

$9.2 Million

Previous $7.32 Million 5.18%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$6.65 - $8.46 $182,742 - $232,480	27,480 Added 2.84%	995,196 $6.94 Million
Q2 2024 Aug 13, 2024	BUY	$6.38 - $15.33 $3.06 Million - $7.34 Million	479,098 Added 98.05%	967,716 $7.32 Million
Q1 2024 May 10, 2024	BUY	$9.78 - $17.5 $738,507 - $1.32 Million	75,512 Added 18.28%	488,618 $6.45 Million
Q4 2023 Feb 14, 2024	BUY	$5.9 - $10.31 $159,423 - $278,586	27,021 Added 7.0%	413,106 $4.26 Million
Q3 2023 Nov 14, 2023	BUY	$4.0 - $9.73 $31,592 - $76,847	7,898 Added 2.09%	386,085 $3.76 Million
Q2 2023 Aug 14, 2023	BUY	$3.98 - $5.12 $324,923 - $417,991	81,639 Added 27.53%	378,187 $1.7 Million
Q1 2023 May 15, 2023	BUY	$1.44 - $5.34 $32,571 - $120,785	22,619 Added 8.26%	296,548 $1.38 Million
Q4 2022 Feb 10, 2023	BUY	$1.29 - $3.67 $171 - $488	133 Added 0.05%	273,929 $408,000
Q2 2022 Aug 12, 2022	SELL	$4.95 - $8.7 $184,001 - $323,396	-37,172 Reduced 11.95%	273,796 $1.36 Million
Q1 2022 May 13, 2022	SELL	$7.06 - $11.57 $861 - $1,411	-122 Reduced 0.04%	310,968 $2.55 Million
Q4 2021 Feb 14, 2022	BUY	$8.63 - $17.36 $145,199 - $292,082	16,825 Added 5.72%	311,090 $3.14 Million
Q3 2021 Nov 12, 2021	BUY	$15.85 - $25.07 $36,280 - $57,385	2,289 Added 0.78%	294,265 $4.66 Million
Q2 2021 Aug 13, 2021	BUY	$19.03 - $26.5 $5.56 Million - $7.74 Million	291,976 New	291,976 $6.95 Million

Others Institutions Holding NPCE

# of Institutions

Shares Held

21.3M

Call Options Held

1.3K

Put Options Held

100

View Full List

About NeuroPace Inc

Ticker NPCE
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,846,900
Market Cap $230M
Description
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...

More about NPCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Neuro Pace Inc Transaction History